AU Patent

AU2012200933B2 — Pyrrolo [2, 3-B] pyridine derivatives as protein kinase inhibitors

Assigned to Plexxikon Inc · Expires 2015-04-30 · 11y expired

What this patent protects

Pyrrolo [2,3-B]pyridine derivatives As Protein Kinase Inhibitors Compounds of formula IlI which are active on protein kinases are descrbed, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases. s (Formula…

USPTO Abstract

Pyrrolo [2,3-B]pyridine derivatives As Protein Kinase Inhibitors Compounds of formula IlI which are active on protein kinases are descrbed, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases. s (Formula Ill).

Drugs covered by this patent

Patent Metadata

Patent number
AU2012200933B2
Jurisdiction
AU
Classification
—
Expires
2015-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Plexxikon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.